HLA CLASS-II ALLELES ASSOCIATED WITH CELIAC-DISEASE SUSCEPTIBILITY IN A SOUTHERN EUROPEAN POPULATION

被引:62
作者
TIGHE, MR
HALL, MA
BARBADO, M
CARDI, E
WELSH, KI
CICLITIRA, PJ
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,RAYNE INST,LONDON SE1 7EH,ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT MED,MOLEC IMMUNOGENET LAB,LONDON,ENGLAND
[3] UNIV ROME LA SAPIENZA,IST CLIN PEDIAT,I-00185 ROME,ITALY
来源
TISSUE ANTIGENS | 1992年 / 40卷 / 02期
关键词
HLA-DR; HLA-DQ; HLA-DP; ITALY;
D O I
10.1111/j.1399-0039.1992.tb01965.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Susceptibility to celiac disease in Northern Europe is associated with the human leukocyte antigens (HLA) B8, DR3 and DQ2, which exist together on an extended haplotype. The strong predominance of this haplotype within the Northern European celiac populations, together with the linkage disequilibrium which occurs between these loci, does not allow identification of the gene(s) primarily associated with disease susceptibility. Studies from Southern Europe using both serology and examination of restriction fragment length polymorphisms (RFLP) have demonstrated associations with DR3, DR7 and DQ2, suggesting that the DQ locus is primarily involved. We investigated 43 celiac patients and 41 healthy controls from Rome, Italy, using sequence-specific oligonucleotide (SSO) probes, in conjunction with gene amplification by the polymerase chain reaction (PCR), to determine alleles at the DRB, DQA1, DQB1 and DPB1 loci: 19% of celiac patients possessed the alleles DRB1*0301 DRB3*0101, 33% DRB1*0301 DRB3*0201 and 33% of celiac patients were heterozygous for DRB1*1101-1201/DRB1*0701. The strongest association with celiac disease susceptibility was the combination of alleles DQA1*0501 DQB1*0201 (91% celiac patients vs. 12% controls; p = 0.000002). There was no additional susceptibility associated with alleles at the DPB locus. This study confirms the hypothesis that susceptibility is associated with a particular combination of DQ alleles and the ethnic variation in DR frequencies is secondary to linkage disequilibrium with these DQ alleles.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 39 条
[1]   EXTENDED MAJOR HISTOCOMPATIBILITY COMPLEX HAPLOTYPES IN PATIENTS WITH GLUTEN-SENSITIVE ENTEROPATHY [J].
ALPER, CA ;
FLEISCHNICK, E ;
AWDEH, Z ;
KATZ, AJ ;
YUNIS, EJ .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) :251-256
[2]   HLA ANTIGENS AND NEUROLEPTIC RESPONSE IN CLINICAL SUBTYPES OF SCHIZOPHRENIA [J].
BERSANI, G ;
VALERI, M ;
BERSANI, I ;
PIAZZA, A ;
ADORNO, D ;
CASCIANI, CU ;
CIANI, N .
JOURNAL OF PSYCHIATRIC RESEARCH, 1989, 23 (3-4) :213-220
[3]   A FAMILY STUDY CONFIRMS THAT THE HLA-DP ASSOCIATIONS WITH CELIAC-DISEASE ARE THE RESULT OF AN EXTENDED HLA-DR3 HAPLOTYPE [J].
BOLSOVER, WJ ;
HALL, MA ;
VAUGHAN, RW ;
WELSH, KI ;
CICLITIRA, PJ .
HUMAN IMMUNOLOGY, 1991, 31 (02) :100-108
[4]   POLYMORPHISMS WITHIN THE HLA-DR3 HAPLOTYPES .1. HLA-DR POLYMORPHISMS DETECTED AT THE PROTEIN AND DNA LEVELS ARE REFLECTED BY T-CELL RECOGNITION [J].
BONTROP, R ;
TILANUS, M ;
MIKULSKI, M ;
VANEGGERMOND, M ;
TERMIJTELEN, A ;
GIPHART, M .
IMMUNOGENETICS, 1986, 23 (06) :401-405
[5]   STRUCTURAL AND SEROLOGICAL SIMILARITY OF MHC-LINKED LMP AND PROTEASOME (MULTICATALYTIC PROTEINASE) COMPLEXES [J].
BROWN, MG ;
DRISCOLL, J ;
MONACO, JJ .
NATURE, 1991, 353 (6342) :355-357
[6]   A COMBINATION OF A PARTICULAR HLA-DP-BETA ALLELE AND AN HLA-DQ HETERODIMER CONFERS SUSCEPTIBILITY TO CELIAC-DISEASE [J].
BUGAWAN, TL ;
ANGELINI, G ;
LARRICK, J ;
AURICCHIO, S ;
FERRARA, GB ;
ERLICH, HA .
NATURE, 1989, 339 (6224) :470-473
[7]   REASSESSMENT OF HLA ASSOCIATION WITH CELIAC-DISEASE IN SPECIAL REFERENCE TO THE DP ASSOCIATION [J].
COLONNA, M ;
MANTOVANI, W ;
CORAZZA, GR ;
BARBONI, P ;
GASBARRINI, G ;
FERRARA, GB ;
TOSI, R ;
TANIGAKI, N .
HUMAN IMMUNOLOGY, 1990, 29 (04) :263-274
[8]  
CONIGA M, 1992, TISSUE ANTIGENS, V39, P78
[9]   THE SARDINIAN HLA-A30,B18,DR3,DQW2 HAPLOTYPE CONSTANTLY LACKS THE 21-OHA AND C4B GENES - IS IT AN ANCESTRAL HAPLOTYPE WITHOUT DUPLICATION [J].
CONTU, L ;
CARCASSI, C ;
DAUSSET, J .
IMMUNOGENETICS, 1989, 30 (01) :13-17
[10]  
COOPER BT, 1987, Q J MED, V63, P269